CAS 2088176-96-7

Formel: C17H12BrN3O2

InChl: InChI=1S/C17H12BrN3O2/c1-2-13-15(21-6-4-3-5-14(21)20-13)17(23)10-7-11(9-19)16(22)12(18)8-10/h3-8,22H,2H2,1H3

InChI Key: RQGCKMOCOOAGEG-UHFFFAOYSA-N

SMILES: CCC1=C(N2C=CC=CC2=N1)C(=O)C3=CC(=C(C(=C3)Br)O)C#N

Lingdolinurad

CAS: 2088176-96-7

Lingdolinurad

Formel: C₁₇H₁₂BrN₃O₂

Reinheit: 96%

Molekulargewicht: 370.2

Ref: 54-BUP08572

Lingdolinurad

CAS: 2088176-96-7

Formel: C₁₇H₁₂BrN₃O₂

Reinheit: 95%

Farbe und Form: Solid

Molekulargewicht: 370.2001

Ref: IN-DA02DI95

3-Bromo-5-(2-Ethylimidazo[1,2-a]pyridine- 3-Carbonyl)-2-Hydroxybenzonitrile

CAS: 2088176-96-7

Formel: C₁₇H₁₂BrN₃O₂

Molekulargewicht: 370.21

Ref: 4Z-P-142098

3-Bromo-5-(2-Ethylimidazo[1,2-a]pyridine- 3-Carbonyl)-2-Hydroxybenzonitrile-13C-D4

CAS: 2088176-96-7

Formel: C₁₆₁₃CH₈D₄BrN₃O₂

Molekulargewicht: 375.22

Ref: 4Z-P-142099

Lingdolinurad

CAS: 2088176-96-7

Formel: C₁₇H₁₂BrN₃O₂

Molekulargewicht: 370.2

Ref: BE-RMCP438090

Lingdolinurad

CAS: 2088176-96-7

Lingdolinurad is a uric acid transporter protein inhibitor targeting hURAT1 for the study of hyperuricemia or gout.

Formel: C₁₇H₁₂BrN₃O₂

Reinheit: 96.05%

Farbe und Form: Solid

Molekulargewicht: 370.2

Ref: TM-T79854